Skip to content
Universidad del Mar SIBUMAR Descubridor Institucional UMAR
  • Inicio
  • Búsqueda avanzada
  • Explorar
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Real world study of pertuzumab-trastuzumab-chemotherapy versus trastuzumab-chemotherapy in neoadjuvant treatment of breast cancer
Cover Image

Real world study of pertuzumab-trastuzumab-chemotherapy versus trastuzumab-chemotherapy in neoadjuvant treatment of breast cancer

Fuente: Redalyc
Saved in:
Bibliographic Details
Main Author: Rocío Díaz-Acedo
Format: Artículo científico
Language:en
Published: Sociedad Española de Farmacia Hospitalaria 2020
Subjects:
Medicina
Pertuzumab
Trastuzumab
Neoadjuvance
Breast cancer
Pathological complete response
Online Access:
Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
  • Holdings
  • Description
  • Comments
  • Similar Items
  • Staff View

Internet

https://www.redalyc.org/articulo.oa?id=365964773005
https://www.redalyc.org/journal/3659/365964773005/
https://www.redalyc.org/journal/3659/365964773005/html/
https://www.redalyc.org/journal/3659/365964773005/365964773005.epub
https://www.redalyc.org/journal/3659/365964773005/movil

Similar Items

  • Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study
    by: Eyyup Cavdar
    Published: (2022)
  • Cardiotoxicity associated with trastuzumab in normal clinical practice
    by: C. Vicente
    Published: (2009)
  • Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report
    by: Patricia Miranda Romero
    Published: (2015)
  • Alertas de cardiotoxicidad en el tratamiento con trastuzumab en cáncer de mama, 4 años de seguimiento
    by: DANIEL A SANTOS
    Published: (2019)
  • An economic evaluation of trastuzumab as adjuvant treatment of early HER2-positive breast cancer patients in Colombia
    by: Jefferson Antonio Buendía
    Published: (2013)
Universidad del Mar
Universidad del MarSistema Bibliotecario de la Universidad del MarDescubridor Institucional UMARImplementación y desarrollo: Mtro. Carlos Alonso Albores Pérez
InicioBúsqueda avanzadaExplorar
Visitas al Descubridor: 387,319© 2026 Universidad del Mar